Oral Vaccines

3D rendering of SARS-CoV-2 virus particles
Biotech

Dynavax pays Vaxart $30M for oral COVID-19 vaccine program

The deal allows Dynavax to see phase 2b data before placing a bigger bet on the program.
Nick Paul Taylor Nov 6, 2025 5:50am
Make a delay and accumulation of outstanding tasks Full stop

Vaxart seeks answers as BARDA vaccine funding dries up again

Aug 12, 2025 5:08am
White mouse sticking its head through a hole in a piece of cheese

Vaccine-probiotic combo clears gut infections in mice

Apr 9, 2025 5:25am
Concept of SARS-CoV-2 or COVID-19

Researchers test under the tongue COVID vaccine in primates

Sep 13, 2023 1:38pm
Gut stomach

Vaxart norovirus vaccine has mixed success in midphase test

Sep 7, 2023 5:31am
Stock imagegraphic of a page titled Norovirus with a stethoscope and oral pills in the frame

Vaxart's oral norovirus vax spurs immune response in ph. 2 trial

Jul 6, 2023 9:52am